Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma

NCT01563029 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01563029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01563029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
March 28, 2012
Completion date
September 24, 2014
Enrollment
597 (actual)
Sites
139

Conditions

As the registry lists them; a condition with its own page is linked.

asthma